¾«Æ·SMÔÚÏßӰƬ

The University of ColoradoÌýConnection

Aspero Medical was founded in 2018 by Ìý(¾«Æ·SMÔÚÏßӰƬ Biomedical, Mechanics of Materials, Robotics and Systems Design) and Ìý() to commercialize the first in a series of innovations that improve patient outcomes from gastrointestinal (GI) endoscopic procedures.ÌýWhile they set out to solve real-life problems for doctors like Edmundowicz, their work was only the beginning. Through their engagement with various Venture Partners at ¾«Æ·SMÔÚÏßӰƬ programs, they honed in on their value proposition and developed a series of additional solutions. With this information and several Advanced Industries Accelerator grants, they cofounded Aspero Medical. The company continued to develop a suite of products with the help of National Institutes of Health (NIH), National Science Foundation (NSF) and Colorado Office of Economic Development and International Trade (OEDIT) grants. In 2023, the company secured clearance from the Food and Drug Administration (FDA) to market and sell its patented Ancora-SB small bowel balloon overtube for small bowel procedures. Additional products are expected to be FDA-cleared in 2026 as the company's portfolio continues to expand.

Funding Status and Investment Opportunities

• Industry Applications: Health and Wellness,ÌýMedical Devices
• Funding Stage: Series A Round
• Contact for Investment Inquiries:Ìý

Technology Development Funding

U.S. National Science Foundation (NSF), Colorado Office of Economic Development and International Trade (OEDIT), U.S. National Institutes of Health (NIH)

ÌýÌý ÌýThis page was last updated on Aug. 15, 2025.ÌýPlease contact vpnews@colorado.edu for corrections or updates